The presence or absence of antibodies to infliximab or adalimumab determines the outcome of switching to etanercept
Year: 2010
Type: article
Study design: Observational Study
Source: Annals of the Rheumatic Diseases
Institutions: Amsterdam UMC Location Vrije Universiteit Amsterdam, Sanquin
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2123170396
